CYTOKINE RELEASE SYNDROME
Clinical trials for CYTOKINE RELEASE SYNDROME explained in plain language.
Never miss a new study
Get alerted when new CYTOKINE RELEASE SYNDROME trials appear
Sign up with your email to follow new studies for CYTOKINE RELEASE SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Home rehab program aims to boost recovery in CAR-T patients
Symptom relief Recruiting nowThis study tests a home-based exercise and nutrition program for 40 adults with lymphoma or myeloma who are about to receive CAR-T cell therapy. Participants follow a personalized plan using a tablet and get support from a rehab team online. The goal is to see if this approach im…
Matched conditions: CYTOKINE RELEASE SYNDROME
Phase: NA • Sponsor: University of Utah • Aim: Symptom relief
Last updated May 26, 2026 08:26 UTC
-
New pill aims to tame dangerous immune overreaction in cancer treatment
Symptom relief Recruiting nowThis study tests an experimental drug called CTO1681 to see if it can prevent or reduce cytokine release syndrome (CRS), a serious side effect of CAR T-cell therapy. About 54 adults with diffuse large B-cell lymphoma will take the drug three times daily for 15 days starting just …
Matched conditions: CYTOKINE RELEASE SYNDROME
Phase: PHASE1, PHASE2 • Sponsor: CytoAgents, Inc. • Aim: Symptom relief
Last updated May 26, 2026 08:19 UTC
-
Blue dye may tame dangerous immune reactions
Symptom relief Recruiting nowThis early-stage study tests whether adding methylene blue to standard care can safely reduce cytokine release syndrome (CRS) and neurotoxicity (ICANS) in 18 adults who developed these side effects after CAR-T or bispecific antibody treatment. Participants receive methylene blue …
Matched conditions: CYTOKINE RELEASE SYNDROME
Phase: PHASE1 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Symptom relief
Last updated May 13, 2026 16:00 UTC